இன்டர்நேஷனல் ஜர்னல் ஆஃப் எமர்ஜென்சி மென்டல் ஹெல்த் அண்ட் ஹ்யூமன் ரெஸிலைன்ஸ்

சுருக்கம்

Most Common Side Effects of Clozapine and Their Management

Mohammad Masud Iqbal, Shivale Swati, Alka Aneja, Mohammad Touhid Iqbal, Esha Aneja and Sumala Haque

Clozapine is a novel, unique and oldest second generation (atypical) antipsychotic agent, first introduced in 1970s in the European market in under trade name, Leponex but has been withdrawn years in 1974 due to development of severe neutropenia (agranulocytosis) resulting in cluster of deaths. It was reintroduced in the early 1990s in United States under trade name, Clozaril by U.S. Food and drug Administration (FDA) for use in treatment resistant schizophrenia in adults and for reduction of risk of persistent suicidal ideation or aggressive behavior in schizophrenic patients. As of today, Clozapine remains the most effective antipsychotic available in reducing both positive and negative symptoms in patients with schizophrenia who fail to respond to typical antipsychotic agent, treating affective disorders, some neurological disorders, aggression, as well as psychosis in patients with dementia and parkinsonism. Most side effects associated with clozapine in general are typically benign, tolerable, and manageable.